Live Price
Live Volume
Chart Volume 0
Volume 0
5 secHalozyme Therapeutics Market Segments
Regular Trading Hours
-0.89(-0.82%)
| Open | $107.96 |
|---|---|
| Close | $107.07 |
| Low | $106.63 |
| Low Change | -1.33 (-1.23%) |
| High | $108.23 |
| High Change | +0.27 (+0.25%) |
| Range | $1.60 |
| Volume | 85.328K |
| Dollar Volume | $9.14M |
Premarket
-0.39(-0.36%)
| Open | $107.00 |
|---|---|
| Close | $106.61 |
| Low | $106.61 |
| Low Change | -0.39 (-0.36%) |
| High | $108.00 |
| High Change | +1.00 (+0.93%) |
| Range | $1.39 |
| Volume | 10.37K |
| Dollar Volume | $1.11M |
Overnight
*No Trades in Segment
After Hours Yesterday
-0.27(-0.25%)
| Open | $107.03 |
|---|---|
| Close | $106.76 |
| Low | $106.76 |
| Low Change | -0.27 (-0.25%) |
| High | $107.03 |
| High Change | +0.00 (+0.00%) |
| Range | $0.27 |
| Volume | 474.268K |
| Dollar Volume | $50.63M |
Regular Trading Hours Yesterday
+0.09(+0.08%)
| Open | $106.93 |
|---|---|
| Close | $107.02 |
| Low | $106.36 |
| Low Change | -0.57 (-0.53%) |
| High | $107.95 |
| High Change | +1.02 (+0.95%) |
| Range | $1.59 |
| Volume | 795.323K |
| Dollar Volume | $85.12M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $107.39 |
|---|---|
| Close | $107.39 |
| Low | $107.39 |
| Low Change | 0.00 (0.00%) |
| High | $107.39 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $21.48K |
Halozyme Therapeutics News
Halozyme Therapeutics Top Trades
Halozyme Therapeutics's top trade so far today returned +1.51%, while the top short trade returned -1.29%.
Halozyme Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $108.74 |
|---|---|
| 10 Day Moving Average (SMA10) | $107.99 |
| 20 Day Moving Average (SMA20) | $106.70 |
| 50 Day Moving Average (SMA50) | $92.52 |
| 100 Day Moving Average (SMA100) | $80.58 |
| 200 Day Moving Average (SMA200) | $74.78 |
Halozyme Therapeutics Statistics
| Average Volume (30 Days) | 2.1M |
|---|---|
| P/E Ratio (Current) | 29.50 |
| EPS (Current) | $3.64 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $806.22M |
| Cash Ratio | 0.47 |
| Current Ratio | 2.71 |
| Quick Ratio | 2.31 |
| Debt to Equity | 14.95 |
| Enterprise Value | $14.17B |
| EV to EBITDA | 13.55 |
| EV to Sales | 8.52 |
| Price to Book | 84.91 |
| Price to Cash Flow | 14.89 |
| Price to Free Cash Flow | 15.12 |
| Price to Sales | 7.33 |
| Return on Assets | 0.16% |
| Return on Equity | 2.88% |
Halozyme Therapeutics Stock Splits
There have been no stock splits for Halozyme Therapeutics (HALO).
Halozyme Therapeutics Dividends
There have been no dividends for Halozyme Therapeutics (HALO).